Healthpeak Properties (DOC) FY2025 10-K Annual Report
Healthpeak Properties (DOC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 3, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Healthpeak Properties FY2025 10-K Analysis
Business Overview
- • Core business model: Own, operate, develop high-quality U.S. healthcare real estate focused on outpatient medical, lab, and senior housing properties
- • New segment emphasis: Preparation for Janus Living IPO, transferring 34 senior housing communities (10,422 units) into a publicly listed REIT structure under majority ownership
- • Strategic shift: Following merger with Physicians Realty Trust, added 299 outpatient medical buildings, expanding scale and tenant base significantly
- • Quantitative metric: Portfolio grew to 689 properties at 12/31/2025; senior housing includes 34 properties plus acquiring remaining 46.5% of SWF SH JV in Jan 2026
- • Noteworthy fact: Senior housing segment redefined to combine life plan communities with sovereign wealth fund JV, reflecting new reportable segment structure for 2025
Management Discussion & Analysis
- • Revenue from resident fees and services $568M in 2024, up $41M YoY from $527M
- • Adjusted NOI $159.6M in 2024 vs $135.6M in 2023, +17.7% YoY, driven by higher fees and occupancy despite higher expenses
- • Best segment: Merger-Combined Same-Store with 17.7% NOI growth; no explicit worst segment disclosed
- • Operating cash flow $1.25B in 2025, up $181M YoY; investing outflows increased $921M; financing activities provided $136M vs $-941M prior year
- • Capital allocation: $94M in common stock repurchases in 2025; dividends increased to $1.22/share annually; $168M development commitments, $9.8B total debt with recent issuances and repayments
- • Forward outlook: Management expects sufficient liquidity for operations, debt service, distributions, and capital needs; notes risks from credit rating downgrades and market conditions impacting borrowing costs
Risk Factors
- • U.S. federal policy shifts (NIH funding cuts, drug pricing, tariffs) creating life science tenant funding uncertainty, risking rent payment and expansion
- • Exposure to Medicare/Medicaid funding cuts and Affordable Care Act subsidy expiration impacting tenants in non-expansion states, affecting outpatient medical segment revenues
- • Tariffs and supply chain disruptions raising construction costs and delaying development projects, increasing capital access risk
- • Competition risk from international biotech sectors in China with favorable regulations diverting R&D investment away from U.S. lab tenants
- • Tenant insolvency risk under U.S. Bankruptcy Code limiting lease remedies and delaying rent collections, especially under master leases across multiple properties
Healthpeak Properties FY2025 Key Financial MetricsXBRL
Revenue
$604M
▲ +6.2% YoY
Net Income
$71M
▼ -70.7% YoY
Net Margin
11.8%
▼ -3096bp YoY
ROE
1.0%
▼ -194bp YoY
Total Assets
$20.3B
▲ +2.0% YoY
EPS (Diluted)
$0.10
▼ -72.2% YoY
Operating Cash Flow
$1.3B
▲ +17.0% YoY
Source: XBRL data from Healthpeak Properties FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Healthpeak Properties
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.